Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...

We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Healthcare shares were in the green, with broad gains in insurance and life sciences. CVS, Cigna and Humana all ended higher. The life-sciences sector finished the week on the right foot, too, with ...

Browse in-depth TOC on HIV Diagnosis Market 332 - Tables 50 - Figures 273 - Pages Based on product type,  the HIV diagnostics ...

The rising incidence of blood disorders and chronic illnesses, along with an increase in accidents and emergency care requirements, is fueling the demand for blood and blood products. Additionally, ...

Solventum (NYSE:SOLV) yesterday announced fourth-quarter results that came in ahead of the consensus forecast on Wall Street.

As tariffs loom, 3M spinoff Solventum’s operating margins are continuing to shrink, and its investors are looking toward the company’s announced purification business sale for balance sheet relief.